Quantum Nano Medicine Research Center
QNM Center is established at Kyoto University as an inbound-type on-site lab. We aim to open up a new field of research emerging from the convergence of Quantum Physics and Nanomedicine.
Papers
More-
Recent Development to Explore the Use of Biodegradable Periodic Mesoporous Organosilica (BPMO) Nanomaterials for Cancer Therapy
-
Studies on the Exposure of Gadolinium Containing Nanoparticles with Monochromatic X-rays Drive Advances in Radiation Therapy
-
Convergence of the Study on Monochromatic X-rays and the Research on Nanoparticles Opens Up a Possibility to Develop a New Type of Radiation Therapy
-
Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug
-
An Organometallic Strategy for Assembling Atomically Precise Hybrid Nanomaterials
-
Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy
-
Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues
-
Biodegradability of Disulfide-Organosilica Nanoparticles Evaluated by Soft X-ray Photoelectron Spectroscopy: Cancer Therapy Implications
-
Synaptic N-6-methyladenosine (m(6)A) epitranscriptome reveals functional partitioning of localized transcripts
-
Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer
-
An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation
-
Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis
LATEST NEWS
MEMBERS
Program-Specific Assistant Professor
Kotaro Matsumoto
Cancer therapy with Nanotechnology
Program-Specific Researcher
Mathilde Laird
Nano-structured materials for cancer therapy
ACCESS
KUIAS-iCeMS Main Building, Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku, Kyoto 606-8501, Japan